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ORIGINAL STUDY
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Adele Myszenski, Barbara Michon, Danielle Lupcke, Cynthia Melican, Narmean Pedawi, Nazir Ahmed,
Janet Fredal Wyman

ABSTRACT
Purpose: Transcatheter aortic valve replacement (tAVR) has emerged as a less-invasive alternative to traditional
surgical aortic valve replacement. The purpose of this study was to examine the effect of a novel clinical pathway with
an emphasis on early physical therapy and occupational therapy on patients undergoing tAVR in the acute care setting.
Methods: A retrospective study was conducted involving 189 patients who underwent tAVR. The control group (n =
74) included patients who underwent tAVR prior to the implementation of the pathway. The intervention group (n =
115) included patients who underwent tAVR following the implementation of the pathway. Inpatient length of stay and
discharge disposition were measured.
Results: No differences in demographics or clinical variables were found; for example, mean age was 79.5 ± 11.2
years, with 57% male in the control group versus 81.6 ± 8.4 years and 59% male in the intervention group. Length of
stay was significantly lower in the intervention group (control 6.9 ± 5.4 days, intervention 4.8 ± 5.4 days, P = .009)
and significantly shorter length of stay postprocedure (control 4.8 ± 2.9 days, intervention 3.5 ± 4.0, P = .015). The
incidence of the patient’s discharge disposition to home increased from 77% of patients in the control group to 86% of
patients in the intervention group but was not statistically significant (P = .118).
Conclusions: A clinical pathway specific to patients post-tAVR provided early mobility, targeted education, individualized functional goals, and discharge disposition recommendations. Patients in the intervention group experienced
reduced hospital length of stay.

T

ranscatheter aortic valve replacement (tAVR)
has emerged as an effective alternative medical
treatment in place of traditional surgical procedures for patients with severe, symptomatic aortic valve
disease.1-7 The procedure replaces the diseased valve
with a self-expanding prosthetic valve via catheter either
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through a femoral access site or through a small incision
in the chest and was initially approved for use by the US
Food and Drug Administration in 2011 for individuals at
high to prohibitive risk for traditional open-heart surgery
via a sternotomy, or surgical aortic valve replacement
(sAVR).8 According to internal records, the first tAVR procedures at Henry Ford Hospital (HFH), Detroit, Michigan,
were completed in 2012 for a total of 46. From 2012 to
2014, volumes tripled to 153 tAVR procedures, and the
rehabilitation (rehab) team identified that these patients
were not receiving physical therapy (PT) and occupational therapy (OT) consults as routinely as those following
sAVR. Patients post-sAVR at HFH followed a postsurgical pathway, including phase I cardiac rehabilitation (see
Figure 1). This pathway was established for patients
undergoing sternotomy, general anesthesia, and cardiopulmonary bypass and anticipated longer periods of bed
rest, hospital stay, and recovery.9-11 The Rehabilitation
Services department proposed that, due to the less-invasive nature of the tAVR procedure, patients likely would
not require the same intensity nor duration of PT or OT
intervention as those on the postsurgical sAVR pathway.
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FIGURE 1. Henry Ford Hospital Inpatient Cardiac Rehabilitation Stages After Cardiac Surgery.

Those who did receive consults following tAVR often
did not receive those consults until several days into hospitalization. Delayed time to PT and OT consults has the
potential to impact outcomes and delay discharge planning, especially for patients with functional deficits.12,13
In 2014, the authors completed a thorough review
of the available literature, which provided no published
protocols or guidelines related to the rehabilitation after
tAVR in the inpatient setting. To address this, a multidisciplinary team composed of an advanced practice nurse,
PTs, and OTs was formed and consulted with the primary
interventional cardiologist on staff at HFH. The team
66
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developed an early intervention PT and OT clinical pathway specific to patients post-tAVR that included targeted
education for patients and families (see Figure 2). The
team implemented that pathway on December 2, 2014.
The purpose of this study was to evaluate patient outcomes before, and after the early intervention, PT and OT
clinical tAVR pathway (tAVR pathway) was implemented.
METHODS
Ethical Considerations and Consent

The hospital’s Institutional Review Board approved the
study design and data collection methods. Informed
JACPT ■ Volume 12 ■ Number 2 ■ 2021
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FIGURE 2. Henry Ford Hospital Inpatient Clinical Pathway After Transcatheter Aortic Valve Replacement Procedure.

consent was waived due to the retrospective nature of the
study.
Study Design

This was a retrospective study involving 189 patients
who received a tAVR procedure via transfemoral catheter percutaneous access site in the catheterization laboratory at HFH from March 1, 2012, through December
31, 2015. Exclusion criteria included access sites other
than femoral, the occurrence of major events including
death, stroke, myocardial infarction (MI), additional
cardiac or vascular surgery, electrophysiological monitoring, pacemaker placement, atrial fibrillation, other car-

diovascular repair or surgery required, gastrointestinal
bleeds, hematoma or access bleeds, or complications.
The control group included patients who underwent
tAVR prior to the implementation of the pathway from
March 1, 2012, through November 1, 2014. The intervention group included patients who underwent tAVR
following the implementation of the pathway from
November 2, 2014, through December 31, 2015. Data
collected included age, gender, body mass index (BMI),
STS Risk Score,14 medical history, 5-m walk test time,
and catheter valve sheath size (French, mm). Outcomes
measured included total hospital length of stay (LOS),
postprocedure LOS, and discharge destination. All data
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were collected from the Society of Thoracic Surgeons
(STS) and the American College of Cardiology (ACC)
STS/ACC TVT Registry, which uses standard definitions
to collection information from participating centers on
consecutive tAVR cases.15
PT/OT Implementation Pathway

The pathway was implemented by a physician-driven order set in the electronic medical record (EMR), which included activity orders for “out of bed with nursing staff”
6 hours post-tAVR and automatic PT and OT consults
for postprocedure day 1. Nurses were trained by a PT
to conduct Dionne’s Egress test to assess the patient’s
ability to safely participate in activities out of bed, including sitting in a chair.16 PT and OT completed separate
evaluations on postprocedure day 1. These evaluations
included functional evaluations, activity monitoring, patient education, recommendation for a discharge destination, and goal setting based on the patient’s functional
level and home situation (see Figure 2). Patients were
seen daily until goals were met or the patient was discharged. Patients were required to have heart rate and
blood pressure monitored pre-, mid- and posttreatment
and documented in the daily therapy notes.17,18 Intervention was terminated with onset or increase in any of the
following: neurologic/visual/orthostatic symptoms within 60 seconds of upright positioning; heart rate increase
more than 30 beats per minute above resting heart
rate; change in systolic blood pressure of 30 mm Hg or
change in diastolic blood pressure of 10 mm Hg; angina,
or shortness of breath. The guidelines for termination of
treatment were based on recommendations by physicians in the cardiology and nephrology departments for
the safe treatment of patients by Physical and Occupational Therapists at HFH.19 PT goals were individualized
to each patient, focusing on the progression of aerobic
capacity for functional transfers, ambulation, and stair
climbing for safe return to the home environment.
Activity was titrated per required metabolic equivalent
of task (MET levels) for phase I cardiac rehab20 and
in response to changes in the patient’s physiological
status. OT goals were also individualized for returning to
independence in basic activities of daily living, including
education and training in energy conservation, task simplification, and adaptive techniques to improve quality
of life upon returning home. Patient education handouts
were developed that included self-monitoring activity
progression, a pedal bike program with an exercise log,
energy conservation techniques, and warning signs of
activity intolerance. PT and OT were directly involved in
recommending discharge plans for a safe transition to
the next level of care.21 Patients who were expected to
return home at discharge were referred to phase II cardiac rehab rehabilitation (2 weeks postdischarge). Those
unable to return home due to functional limitations and
lack of home support were referred to a postacute rehabilitation facility.
68
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Statistical Analysis

All continuous data were tested for normality and are
described using means and standard deviations, while
categorical data are described using counts and column percentages. Univariate 2-group comparisons
were performed using χ2 and Fisher’s exact tests (when
expected cell counts are <5) for categorical variables,
using 2-group t tests and Wilcoxon rank-sum tests (when
normality distributions were violated) for continuous
variables. Statistical significance was set at P < .05. All
analyses were performed using SAS 9.4 (SAS Institute,
Cary, North Carolina).
RESULTS
Patient demographics and medical history were compared for all patients in the study, as detailed in Table 1.
No significant differences in age, gender, BMI, or STS risk
factor were found between the 2 groups. The incidence
of other comorbidities or prior surgical procedures was
comparable between the 2 groups, with 3 exceptions:
1. Patients in the control group had a higher rate of recent heart failure than their counterparts (intervention
42%, control 27%, P = .03).
2. Conversely, patients in the control group had a lower
rate of prior MI than those in the control group (intervention 33%, control 20%, P = .06).
3. The 5-m walk test scores were collected for more
patients in the intervention group than in the control
group (intervention 74%, control 50%, P < .001).
For those who participated in the 5-m walk test, 22%
of patients in the control group were unable to walk,
compared with 7% in the intervention group. In addition,
more patients in the intervention group (45%) required
greater than 6 seconds to walk 5 m than those in the
control group (9%).
Catheter valve sheath delivery size was larger in the
intervention group (control 18.1 ± 4.2 mm, intervention
19.3 ± 3.8 mm, P = .04). The average total hospital
LOS for patients in the intervention group was 2.1 days
shorter in the intervention group (control 6.9 ± 5.4 days,
intervention 4.8 ± 5.4 days, P = .009). The average
postprocedure LOS was also significantly shorter in
the intervention group (control 4.8 ± 2.9 days, intervention 3.5 ± 4.0 days, difference 1.3 days, P = .015). The
percentage of patients discharged to home rather than
to a rehab facility was 13 percentage points higher in the
intervention group but did not meet criteria for statistical
significance. All data are reported in Tables 1 and 2.
DISCUSSION
This study aimed to determine whether an early PT and
OT intervention pathway in the tAVR population would
improve patient outcomes. Our retrospective study
demonstrates shorter hospital lengths of stay overall
and postprocedure LOS for those who participated in
JACPT ■ Volume 12 ■ Number 2 ■ 2021
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TABLE 1. Descriptive Statistics and 2-Group Comparisons
Variable (Count)

Control Group
(n = 74)

Intervention Group
(n = 115)

Test Statistic
(df)

P Value

Age, mean ± SD, y

79.5 ± 11.2

81.6 ± 8.4

−1.37 (125)

.17

42 (57%)

68 (59%)

0.10 (1)

.75

BMI, mean ± SD

28.4 ± 6.2

28.4 ± 6.1

−0.02 (154)

.99

STS Risk Score, mean ± SD

8.5 ± 8.5

7.0 ± 4.6

1.35 (102)

.18

Hypertension

66 (89%)

108 (94%)

1.38 (1)

.24

Afib/aflutter

29 (40%)

48 (42%)

0.07 (1)

.78

Prior MI

15 (20%)

38 (33%)

3.64 (1)

.06

Prior CABG

17 (23%)

26 (23%)

0.003 (1)

.95

Prior stroke

12 (16%)

9 (8%)

3.21 (1)

.07

Previous AV balloon

30 (41%)

36 (31%)

1.69 (1)

.19

2 (3%)

0 (0%)

3.14 (1)

.08

Chronic lung disease

28 (38%)

37 (32%)

0.64 (1)

.42

Heart failure prior 2 wk

31 (42%)

31 (27%)

4.56 (1)

.03

Diabetes

27 (36%)

49 (43%)

0.70 (1)

.40

33.71 (4)

<.001

−2.07 (187)

.04

Gender: male

Previous AV repair

5-m walk test prior
Not performed

37 (50%)

30 (26%)

Unable to walk

16 (22%)

8 (7%)

≤6 s

14 (19%)

26 (23%)

>6 but ≤10 s

3 (4%)

34 (30%)

>11 s

4 (5%)

17 (15%)

18.1 ± 4.2

19.3 ± 3.8

Valve sheath delivery,
mean ± SD, French, mm

Afib, atrial fibrillation; AV, aortic valve; BMI, body mass index; CABG, coronary arterial bypass graph; MI, myocardial infarction; N/A, unable to
complete statistical test due to low incidence; STS Risk Score, Society of Thoracic Surgery Risk Score.

the pathway compared with historical controls. Although
the percentage of patients returning home at discharge
was not statistically significant, the incidence did slightly
increase after the pathway was implemented. While the
benefits of early intervention by PT and OT in the acute
care setting are well established in the literature,22-24
studies specific to patients’ status post-tAVR have not
been published previously. Daily PT and OT interventions
were likely contributors to patients meeting functional

goals in a shorter timeframe for discharge home. The
authors hypothesize that several additional factors contributed to the success and of the tAVR pathway, including the multidisciplinary collaboration in the design and
implementation of the program. Other factors included
having an automatic order set for PT and OT consults in
the EMR that were placed immediately postprocedure
and streamlined the process of evaluation, treatment,
and monitoring of all patients undergoing tAVR.

TABLE 2. Patient Outcomes: Descriptive Statistics and 2-Group Comparison
Control Group
(n = 74)

Intervention Group
(n = 115)

Test Statistic
(df)

P Value

Postprocedure LOS, mean ± SD, d

4.8 ± 2.9

3.5 ± 4.0

2.46 (184)

.015

Total LOS, mean ± SD, d

6.9 ± 5.4

4.8 ± 5.4

2.64 (187)

.009

Home discharge disposition
(count, % of total)

57 (77%)

99 (86%)

4.28 (2)

.118

Rehab facility discharge disposition (count, % of total)

17 (23%)

16 (14%)

Variable

LOS, length of stay.
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Additionally, mobility training encouraged nursing
staff to adhere to the expected mobilization of patients 6 hours postprocedure. The development of
tAVR-specific educational materials provided written
documentation of verbal instruction to reinforce training
provided during PT and OT evaluation and intervention. Consistent and timely documentation in the EMR
promoted clear communication among service providers
throughout patients’ continuum of care. Finally, early
recommendations for discharge destination from PT and
OT helped coordinate discharge planning.
PT’s and OT’s early intervention on day 1 post-tAVR
likely provided the patient and medical team with defined
therapeutic goals, as well as accurate and appropriate
discharge recommendations, as Smith et al21 found in
a 2010 study. Daily PT and OT interventions were also
likely contributors to patients meeting functional goals
in a shorter timeframe for discharge home. The authors
hypothesize that several additional factors contributed
to the success and of the tAVR pathway, including the
multidisciplinary collaboration in the design and implementation of the program. Other factors included having
an automatic order set for PT and OT consults in the
EMR that were placed immediately postprocedure and
streamlined the process of evaluation, treatment, and
monitoring of all patients undergoing tAVR. Additionally,
mobility training encouraged nursing staff to adhere to
the expected mobilization of patients 6 hours postprocedure. The development of tAVR-specific educational
materials provided written documentation of verbal
instruction to reinforce training provided during PT and
OT evaluation and intervention. Consistent and timely
documentation in the EMR promoted clear communication among service providers throughout patients’
continuum of care. Finally, early recommendations for
discharge destination from PT and OT helped coordinate
discharge planning.
The authors acknowledge several limitations in this
study. The retrospective study design introduces selection bias and limits study results and generalizability.
Data on frequency and timing of PT and OT could not
be captured, as all documentation was recorded on
paper to November 2014. Additionally, the patient’s level
of function prior to cardiac surgery was not accounted
for, which may have impacted the results. The patient’s
level of social support was not taken into consideration,
which could have affected discharge recommendations.
Discharge disposition recommendations are made at
the discretion of the PT or OT assessing the patient,
which involves clinical judgment. Objective measurements guided this clinical decision-making (ie, levels of
assistance required, vital sign response to activity, etc);
however, all clinical decision-making involves a degree
of subjective judgment, which is difficult to measure
and may have impacted this study in ways the authors
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could not control. Finally, the STS Risk Score, which is a
common indicator used by interventional cardiologists
prior to tAVR, was developed for patients undergoing
traditional cardiac surgery,14 thus limiting its applicability
to the tAVR population.
Overall, the authors were encouraged to continue
the use of the tAVR pathway in this surgical population
due to the potential effect on patient outcomes. Early
PT and OT intervention following tAVR appears to promote statistically significant shorter inpatient LOS, and
possibly increased discharge home versus to a rehab
facility. Further research is needed to determine the
effect of patients’ preoperative level of function, level
of social support, and clinician judgment on discharge
recommendations. Future studies should include the
use of standardized functional tests post-tAVR, STS
Risk scores calculated specifically for patients who
undergo a tAVR procedure, assessment of a patient’s
prior level of function, and comorbid conditions pretAVR procedure and long-term outcomes. Supplementary research may consider more detailed records of
PT and OT interventions to determine whether specific
treatments have improved efficacy or altered patient
outcomes. The authors intend to assess results of the
implementation of the tAVR pathway for intermediate
and/or lower-risk patient populations, as transcatheter procedures have become the recommended
alternative to sAVR for high-risk patients, and studies
continue to investigate the efficacy of tAVR for patients in lower risk populations.6,25,26 Additionally, the
authors recommend expanding the pathway program
to include patients post-tAVR regardless of catheter
access site, transcatheter mitral valve replacement
(tMVR), and other minimally invasive catheter-based
procedures.26,27
CONCLUSION
This early intervention PT and OT clinical pathway specific to patients post-tAVR provided early mobility, targeted
education, individualized functional goals, and discharge
disposition recommendations. Upon implementation
of this tAVR pathway, patients experienced reduced
hospital LOS, reduced postprocedure LOS, and a trend
toward a higher incidence of discharge home versus a
rehabilitation facility. Upon implementation of this tAVR
pathway, patients experienced reduced hospital LOS
and postprocedure LOS and a trend toward a slightly
higher incidence of discharge home versus rehabilitation
facility. Further research is needed to determine optimal
parameters within the pathway protocol and expand the
pathway to more inclusive populations as advancements
in transcatheter procedures, and standardized care continues. This study suggests that an acute care PT and
OT early intervention clinical pathway is feasible and can
impact hospital and postprocedure LOS.
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